NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/14/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.25 mln
Float0.48 mln
Earnings Date08/14/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
ROE
-270
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Genprex is an Austin, Texas-based company founded in 2009 that develops gene-based treatments for cancer and diabetes. In oncology, its lead candidate Reqorsa is being tested in multiple clinical trials for lung cancer and has received both Fast Track and Orphan Drug designations from the FDA. For diabetes, the company is working on a therapy that delivers specific genes to the pancreas to restore insulin production, with different approaches for Type 1 and Type 2 patients.
